Compounding pharmacies producing cheaper semaglutide products have been given notice they will soon have to stop, as the drug is no longer on the FDA shortage list.
U.S. Food & Drug Administration. “Declaratory Order: Resolution of Shortages of Semaglutide Injection Products (Ozempic and Wegovy).” U.S. Food & Drug Administration. “FDA Clarifies Policies for ...